| 2024/07/17 20:00:16 | |
|---|---|
| Price | |
| 47.00 USD | |
| Difference | -2.39% (-1.15) |
General attributes
| ISIN | CH0011432447 |
| Symbol | BSLN |
| Exchange | FINRA other OTC Issues |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 520 EUR |
| Benchmark | SWISS MARKET INDEX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 47.00 USD |
| High | 47.00 USD |
| Low | 47.00 USD |
| Close (prev. day) | 48.15 USD |
| VWAP | 47.00 USD |
| Volume (pcs) | 11 |
| Trading volume | 517.00 |
| Number of trades | 1 |
| Last size | 11 |
Futures and Options
| Related Futures | 15 |
| Related Options | - |
PDF Downloads
| Company report: BASILEA PHARMACEU |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/05/29 |
|
Global Equity Ratings |
|
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/07/17 20:00:16 | |
|---|---|
| Price | |
| 47.00 USD | |
| Difference | -2.39% (-1.15) |
General attributes
| ISIN | CH0011432447 |
| Symbol | BSLN |
| Exchange | FINRA other OTC Issues |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 520 EUR |
| Benchmark | SWISS MARKET INDEX |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 47.00 USD |
| High | 47.00 USD |
| Low | 47.00 USD |
| Close (prev. day) | 48.15 USD |
| VWAP | 47.00 USD |
| Volume (pcs) | 11 |
| Trading volume | 517.00 |
| Number of trades | 1 |
| Last size | 11 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +17.44% | -3.70% | +4.59% |
| Perf (abs.) | +7.15 | -1.85 | +2.12 |
| Beta | 0.75 | 0.56 | 0.88 |
| Volatility | 64.21 | 146.25 | 130.68 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | - USD (-) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 46.30 USD (10) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 42.99 USD (6) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 43.83 USD (3) |
| YTD High | date | 48.15 USD (2024/05/20) |
| YTD Low | date | 38.60 USD (2024/01/23) |
| 52 Weeks High | date | 50.00 USD (2023/05/22) |
| 52 Weeks Low | date | 38.60 USD (2024/01/23) |
All listings for BASILEA PHARMACEU
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Stuttgart | 2019/06/28 | 17:19 | 32.60 EUR | 0.02 | 8 |
| SIX Swiss Exchange | 2024/07/17 | 17:30 | 42.00 CHF | 1.12 | 324 |
| London Stock Exchange | 2024/01/25 | 17:32 | 34.0277 CHF | 0.23 | 1 |
| Frankfurt | 2019/06/28 | 15:43 | 32.28 EUR | 0.00 | 3 |
| FINRA other OTC Issues | 2024/07/17 | 20:00 | 47.00 USD | 0.00 | 1 |
Company Logo
Contact Details
| BASILEA PHARMACEUTICA AG |
| - - |
| Hegenheimermattweg 167b - 4123 Allschwil |
| Telefon: +41-61-606-11-11 |
| Fax: + |
| E-mail: info@basilea.com |
PDF Downloads
| Company report: BASILEA PHARMACEU | |
Company Profile
Basilea Pharmaceutica AG engages in the development and commercialization of pharmaceutical products. Its products include antifungals and antibiotics. The company was founded on October 17, 2000, and is headquartered in Allschwil, Switzerland. |
Members of Management Board
| David Veitch | Chairman of Managing Board |
| Gerrit Hauck | Member of Executive Committee |
| Laurenz Kellenberger | Member of Executive Committee |
| Marc Engelhardt | Member of Executive Committee |
| Adesh Kaul | Member of Executive Committee |
Board of directors
| Alf Gunnar Martin Nicklasson | Member of the administrative board |
| Carole Sable | Member of the administrative board |
| Nicole Onetto | Member of the administrative board |
| Thomas Werner | Member of the administrative board |
| Leonard Kruimer | Member of the administrative board |
| Domenico Scala | Chairman of the administrative boar |